Top 10 Leading Companies in Robotic Biopsy Devices Industry
The global robotic biopsy devices market size is expected to reach USD 703.7 million by 2026, according to a new report by Grand View Research, Inc., registering a 11.3% CAGR over the forecast period. Rising cancer incidence and increasing demand for minimally invasive surgeries are leading factors contributing toward this growth. Moreover, growing need for high precision while performing biopsies of delicate organs, without distressing surrounding nerves, is expected to drive the market.
On the basis of product type,
robot-assisted biopsy devices are classified into systems and instruments &
accessories. The systems segment is expected to grow at the fastest pace over
the forecast period. Increasing launch of innovative biopsy robots and growing
acquisition activities among key players have supported the growth of this
segment. For instance, in September 2018, XACT Robotics received a CE mark for
its robotics system, which gave the company entry into the European market.
Moreover, in April 2019, Johnson & Johnson acquired robotic start-up Auris
Health and obtained ownership of its Monarch Platform.
Browse Full Report with TOC and Free Sample
Copy@ https://www.grandviewresearch.com/industry-analysis/robotic-biopsy-devices-market
The lung biopsy segment dominated the
market in terms of application, with a revenue of USD 132.4 million in 2018. Rising incidence of lung cancer worldwide
and need for higher precision devices are some of the major factors driving the
market. Robot assisted devices enable surgeons to access deep nodules within
the lungs, that are too small and difficult to access manually. Moreover, this
segment is expected to witness the fastest growth over the forecast period
owing to continuous rise in the number of tobacco smokers in many Asian and
European countries.
North America dominated the market in 2018,
owing to high healthcare spending, presence of major robot manufacturers in
this region, and growing penetration of robotic devices in healthcare settings.
On the other hand, the Asia Pacific region is anticipated to grow at the
fastest rate over the forecast period, owing to ongoing research and
development on robotics in countries such as Japan and South Korea, and rising
incidence of cancer in the region.
Contact
Us:
Grand View Research, Inc.
201 Spear Street 1100,
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment